docetaxel anhydrous has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, H; Imanaka-Yoshida, K; Kamikura, Y; Saito, K; Sekine, T; Takeda, K | 1 |
| Sparano, JA | 1 |
1 review(s) available for docetaxel anhydrous and Cardiomyopathies
| Article | Year |
|---|---|
Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiomyopathies; Clinical Trials as Topic; Docetaxel; Doxorubicin; Heart; Humans; Neoplasm Metastasis; Paclitaxel; Taxoids | 1999 |
1 trial(s) available for docetaxel anhydrous and Cardiomyopathies
| Article | Year |
|---|---|
Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Cardiomyopathies; Docetaxel; Fatty Acids; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Taxoids; Technetium Tc 99m Sestamibi | 2003 |